中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
10期
15-15,17
,共2页
6-氨基己酸%尼莫地平%蛛网膜下腔出血
6-氨基己痠%尼莫地平%蛛網膜下腔齣血
6-안기기산%니막지평%주망막하강출혈
6-aminocaproic acid%Nimodipine%Subarachnoid hemorrhage
目的：对蛛网膜下腔出血用6-氨基己酸联合尼莫地平注射液治疗的效果进行评价。方法：收治蛛网膜下腔出血患者98例，联合应用6-氨基己酸与尼莫地平注射液进行治疗，观察患者治疗3天、7天、2周后的治疗效果、并发症以及不良反应。结果：全组98例患者治疗3天、7天、2周后的总有效率分别69.39%、80.61%、92.86%，全组出现再出血17例(17.35%)，出现脑缺血18例(18.37%)，出现脑积水19例(19.39%)。治疗中出现恶心3例(3.06%)，血压下降4例(4.08%)，不良反应发生率7.14%。结论：对蛛网膜下腔出血病症采用6-氨基己酸和尼莫地平注射液进行联合治疗总有效率较高，同时能较好降低并发症的风险及再次出血的概率。
目的：對蛛網膜下腔齣血用6-氨基己痠聯閤尼莫地平註射液治療的效果進行評價。方法：收治蛛網膜下腔齣血患者98例，聯閤應用6-氨基己痠與尼莫地平註射液進行治療，觀察患者治療3天、7天、2週後的治療效果、併髮癥以及不良反應。結果：全組98例患者治療3天、7天、2週後的總有效率分彆69.39%、80.61%、92.86%，全組齣現再齣血17例(17.35%)，齣現腦缺血18例(18.37%)，齣現腦積水19例(19.39%)。治療中齣現噁心3例(3.06%)，血壓下降4例(4.08%)，不良反應髮生率7.14%。結論：對蛛網膜下腔齣血病癥採用6-氨基己痠和尼莫地平註射液進行聯閤治療總有效率較高，同時能較好降低併髮癥的風險及再次齣血的概率。
목적：대주망막하강출혈용6-안기기산연합니막지평주사액치료적효과진행평개。방법：수치주망막하강출혈환자98례，연합응용6-안기기산여니막지평주사액진행치료，관찰환자치료3천、7천、2주후적치료효과、병발증이급불량반응。결과：전조98례환자치료3천、7천、2주후적총유효솔분별69.39%、80.61%、92.86%，전조출현재출혈17례(17.35%)，출현뇌결혈18례(18.37%)，출현뇌적수19례(19.39%)。치료중출현악심3례(3.06%)，혈압하강4례(4.08%)，불량반응발생솔7.14%。결론：대주망막하강출혈병증채용6-안기기산화니막지평주사액진행연합치료총유효솔교고，동시능교호강저병발증적풍험급재차출혈적개솔。
Objective:To explore the application effect of 6-aminocaproic acid combined with nimodipine injection in subarachnoid hemorrhage.Methods: 98 patients with subarachnoid hemorrhage were selected from 2010 March to 2013 June.They were treated by combined 6-aminocaproic acid and nimodipine injection.We observed the therapeutic effect,complications and adverse reactions of them in 3 days,7 days and 2 weeks after treatment.Results:In the whole group of 98 patients,the total effective rate for 3 days,7 days,2 weeks after treatment were 69.39% ,80.61% ,92.86% respectively;In all patients,17 cases had bleeding(17.35%);18 cases had cerebral ischemia(18.37%);19 cases had hydrocephalus(19.39%).During the treatment,3 caseshad nausea(3.06%),4 cases had decreased blood pressure(4.08%),the incidence of adverse reaction was 7.14%.Conclusion:The total efficiency of 6-aminocaproic acid combined with nimodipine injection in subarachnoid hemorrhage is high.At the same time,it can reduce the risk of complications and the probability of bleeding again.
